Oseltamivir adherence and tolerability in health care workers treated prophylactically after occupational influenza exposure

Am J Infect Control. 2012 Dec;40(10):1020-2. doi: 10.1016/j.ajic.2011.11.014. Epub 2012 Mar 21.

Abstract

This survey of health care workers who were prescribed oseltamivir prophylaxis after occupational exposure to 2009 pandemic influenza A (H1N1) documents their adherence, adverse effects, development of influenza-like illness, and knowledge and beliefs about the treatment and transmission of influenza. Adverse effects occurred in 15 of 36 participants evaluated (41.6%). The majority of the participants understood that influenza is highly infective and would take oseltamivir again, although 40.5% (15 of 37) thought they had not been given sufficient information about adverse effects.

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use
  • Attitude of Health Personnel
  • Chemoprevention / adverse effects*
  • Chemoprevention / methods*
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Female
  • Health Knowledge, Attitudes, Practice
  • Health Personnel*
  • Humans
  • Influenza, Human / prevention & control*
  • Male
  • Medication Adherence*
  • Oseltamivir / adverse effects*
  • Oseltamivir / therapeutic use*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Oseltamivir